Back to Search
MATTHEW TOLLEFSON, M.D.
M.D.
Urology Physician
NPI: 1316927114IndividualAccepts Medicare
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
46881(MN)
CMS Specialties
PrimaryUROLOGY
Education
MAYO MEDICAL SCHOOL
Class of 2003
Research & Publications (20)
Long-term outcome of ureterosigmoidostomy: an analysis of patients with >10 years of follow-up.
PMID 19681892·BJU Int·2010
8-other
Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other.
PMID 17594714·Cancer·2007
8-other
Stratification of patient risk based on prostate-specific antigen doubling time after radical retropubic prostatectomy.
PMID 17418069·Mayo Clin Proc·2007
8-other
Contemporary imaging modalities for the surveillance of patients with renal cell carcinoma.
PMID 17239315·Curr Urol Rep·2007
6-review
En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients.
PMID 17147965·J Am Acad Dermatol·2007
8-other
Traumatic obliterative urethral strictures in pediatric patients: failure of the cut to light technique at long-term followup.
PMID 17707030·J Urol·2007
8-other
Incidence and types of childhood hypertropia: a population-based study.
PMID 16647125·Ophthalmology·2006
8-other
Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival.
PMID 16406993·J Urol·2006
8-other
In situ partial nephrectomy and tumor thrombectomy for renal cell carcinoma with level II vena cava extension in a solitary kidney.
PMID 16230173·Urology·2005
5-case
Intraductal papillary mucinous neoplasm: did it exist prior to 1980?
PMID 12657965·Pancreas·2003
8-other
Investigation of aminopyridiopyrazinones as PDE5 inhibitors: Evaluation of modifications to the central ring system.
PMID 19539468·Bioorg Med Chem Lett·2009
7-preclinical
Optimization of the aminopyridopyrazinones class of PDE5 inhibitors: discovery of 3-[(trans-4-hydroxycyclohexyl)amino]-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido[3,4-b]pyrazin-2(1H)-one.
PMID 19631533·Bioorg Med Chem Lett·2009
7-preclinical
Identification, synthesis and SAR of amino substituted pyrido[3,2b]pyrazinones as potent and selective PDE5 inhibitors.
PMID 19540112·Bioorg Med Chem Lett·2009
7-preclinical
Iatrogenic ureteral injury: can adult repair techniques be used on children?
PMID 18945640·J Pediatr Urol·2009
4-observational
Functional and oncological outcomes after orthotopic neobladder reconstruction in women.
PMID 18990170·BJU Int·2008
8-other
Soft-tissue swelling around the proximal interphalangeal joints bilaterally: pachydermodactyly.
PMID 19075157·Arch Dermatol·2008
5-case
Convergent, parallel synthesis of a series of beta-substituted 1,2,4-oxadiazole butanoic acids as potent and selective alpha(v)beta3 receptor antagonists.
PMID 16298127·Bioorg Med Chem Lett·2006
8-other
Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 2).
PMID 16134951·J Med Chem·2005
7-preclinical
Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 1).
PMID 16134950·J Med Chem·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 1ST ST SW
ROCHESTER, MN 55905 - Phone
- (507) 284-2511
Quick Facts
- NPI
- 1316927114
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 23
- Publications
- 20
Are you this provider?
Claim Your Profile